CNS Pharmaceuticals
CNSP
CNSP
23 hedge funds and large institutions have $343K invested in CNS Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$0 |
| 2 |
BFA
2
Beacon Financial Advisory
Cleveland,
Ohio
|
$0 |
| 3 |
3
BlackRock
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$6K |
| 5 |
5
Two Sigma Investments
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
26
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $0 | 10 | – | – |
|
|
UWM
28
Urban Wealth Management
El Segundo,
California
| $0 | 100 | +100 | New |
|